Pfizer seeking FDA OK for COVID-19 vaccine booster dose
By TOM MURPHY AP Health Writer Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker announced Wednesday that it has started the approval process for a third dose of its vaccine for all Americans ages 16 and older. The company said it expects to complete its application with
Continue Reading